Aqueous pharmaceutical compositions of 2,6-diisopropylphenol (propofol) and their uses
AssigneeJanssen Biotech, Inc.
InventorsZhong Zhang, Orn Almarsson, Hongming Chen
Life of this patent
Estimating the term…
Loading patent…
AssigneeJanssen Biotech, Inc.
InventorsZhong Zhang, Orn Almarsson, Hongming Chen
Estimating the term…
The present invention provides aqueous pharmaceutical compositions containing a lipophilic therapeutic agent. In particular, the invention provides aqueous pharmaceutical compositions containing the compound 2,6-diisopropylphenol (propofol). Preferred compositions of the invention contain propofol in the presence of at least one block copolymer (for example, P188 or another poloxamer) and a polyethylene glycol (PEG). Compositions of the invention are preferably sterile or are readily sterilized (e.g., by autoclaving) and are suitable for parenteral administration to any animal, including humans. The compositions are also chemically and physically stable over a wide range of environmental conditions and for extended periods of time.
An aqueous formulation consisting essentially of, on a gram per 100 ml (reported as %) basis:
An aqueous formulation consisting essentially of, on a gram per 100 ml (reported as %) basis:
An aqueous formulation consisting essentially of, on a gram per 100 ml (reported as %) basis:
An aqueous formulation consisting essentially of, on a gram per 100 ml (reported as %) basis:
An aqueous formulation consisting essentially of, on a gram per 100 ml (reported as %) basis:
A formulation comprising an injectable anesthetic solution, including at least one preservative as an optional component, the formulation including no more than 15% (weight/volume grams/100 ml) excipients and consisting essentially of, in addition to said optional components, a clear aqueous composition selected from the group consisting of:
Dependencies are inferred from the claim text.